ESC 365 - Doctor Christian Basile

Speaker illustration

Doctor Christian Basile

Karolinska Institute, Stockholm (Sweden)

Member of:

Heart Failure Association

Presentations Articles

Cardiac resynchronization therapy in heart failure: a target trial emulation study

Event: Heart Failure 2025

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Latest registries and observational studies

Age- and sex-related differences in heart failure characteristics and treatment patterns across the ejection fraction spectrum

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Towards optimisation of heart failure therapies

Clinical characteristics and predictors of successful decongestion in patients with acute heart failure: data from the nationwide BRING-UP3 HF study

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Diuretic treatment and decongestion

The prognostic role of history of cerebrovascular events in patients with heart failure

Event: Heart Failure 2025

Topic: Comorbidities

Session: Cardiometabolic and multisystem interactions in heart failure

Clinical characteristics and predictors of successful decongestion in patients with acute decompensated heart failure

Event: ESC Acute CardioVascular Care 2025

Topic: Pharmacotherapy

Session: Young Investigators Award

Use and associations with mortality/morbidity of guideline-directed medical therapy use in heart failure with improved ejection fraction: a PS-matched analysis from the swedish heart failure registry

Event: ESC Congress 2024

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Optimisation of heart failure treatment

Enhancing the selection of heart failure patients for invasive procedures: how machine learning can predict the diagnostic yield of endomyocardial biopsy

Event: ESC Congress 2024

Topic: Invasive Haemodynamic Monitoring

Session: Get out your crystal ball: predicting heart failure events using models

Time to first clinical benefit in heart failure with preserved ejection fraction: a study-level meta-analysis of randomized controlled trials with reconstructed time-to-event data

Event: Heart Failure 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Tailoring heart failure therapies on patient profiles

Use of inclisiran in a real-world setting: results from the italian Cholinet registry

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session: PCSK9 inhibitors and inclisiran

Efficacy and safety of inclisiran in real world practice: insights from the Cholinet registry

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session: PCSK9 inhibitors and inclisiran

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources